Search results
Order by most recent / most popular / relevance
Results: 1-6 of 6
Judgment of the European Court of Justice in the GSK dual pricing case
- Bird & Bird
- -
- European Union
- -
- October 13 2009
The European Court of Justice ("ECJ") has given judgment on the appeals of the European Commission, GSK and two trade associations against the judgment of the European Court of First Instance ("ECFI") in the GSK dual pricing parallel exports case, Joined Cases C-50106P, C-51506P and C-51906P, GlaxoSmithKline Services Unlimited, formerly Glaxo Wellcome plc v Commission and Commission, EAEPC and Aseprofar v GlaxoSmithKline Services Unlimited, formerly Glaxo Wellcome plc
European Commission’s pharmaceutical sector inquiry final report
- Bird & Bird
- -
- European Union
- -
- September 25 2009
In July 2009, the European Commission published its final report in its pharmaceutical sector inquiry, which was launched in January 2008
Opinion of the Advocate General in the GSK dual pricing case pending before the European Court of Justice
- Bird & Bird
- -
- European Union
- -
- July 17 2009
Advocate General Trstenjak has delivered her opinion on the appeals of the European Commission, GSK and two trade associations against the judgment of the European Court of First Instance ("ECFI") in the GSK dual pricing parallel exports case, Joined Cases C- 50106P, C-51506P and C-51906P, GlaxoSmithKline Services Unlimited, formerly Glaxo Wellcome plc v Commission and Commission, EAEPC and Aseprofar v GlaxoSmithKline Services Unlimited, formerly Glaxo Wellcome plc
European General Court upholds findings of abuse of dominant position by AstraZeneca for misusing the SPC and marketing authorising systems
- Bird & Bird
- -
- European Union
- -
- July 28 2010
The European General Court issued its judgment on 1 July 2010 on AstraZeneca's appeal against the European Commission's decision adopted on 15 June 2005 fining AstraZeneca ("AZ") EUR 60 million for abuse of dominant position through misuse of the patent system to obtain supplementary protection certificates (SPCs) and misuse of the pharmaceutical regulatory system by selective withdrawal of certain marketing authorisations
European Commission reports on the monitoring of patent settlement agreements
- Bird & Bird
- -
- European Union
- -
- July 27 2010
In the European Commission's pharmaceutical sector enquiry report of July 2009, the Commission drew attention to patent settlement agreements between originator and generic companies, indicating that these can raise competition law issues in particular where there is a value transfer from the originator, patent owning company to the generic company in return for delayed market entry or limits on market entry on the part of the generic company
Monitor to gain competition law powers from 1 April
- Bird & Bird
- -
- United Kingdom
- -
- February 11 2013
Monitor, the NHS regulator, is to have powers to apply competition law to healthcare service providers from 1 April 2013. The competition law
Current Search
- Firm Name - Bird & Bird
- Workarea - Healthcare
- Workarea - Competition
- Author - Richard Eccles